Neohecogenin-3-O-beta-D-glycopyranoside

NeoHecogenin 3-O-β-D-Glucopyranoside

1. Identity and Chemical Characterization

1.1 Nomenclature and Chemical Classification

NeoHecogenin 3-O-β-D-glucopyranoside (also rendered in commercial supplement labeling as NeoHecogenine-3-0-Beta-D-Glycopyranoside) is a steroidal saponin belonging to the spirostane class of steroid glycosides. Its name describes both the aglycone (sapogenin) component — neohecogenin — and the attached sugar moiety: a single β-D-glucopyranose unit linked via a glycosidic bond at the C-3 hydroxyl position of the steroid. The compound is catalogued in the phytochemical literature on steroid glycosides, with spectroscopic reference data formally published in the reference volume Spectroscopic Data of Steroid Glycosides: Stigmastanes, Furostanes, Spirtostanes (Springer, 2006). This compound appears in the 2006 Springer reference work on spectroscopic data of steroid glycosides covering stigmastanes, furostanes, and spirtostanes.

The aglycone neohecogenin is structurally closely related to hecogenin. Hecogenin's IUPAC name is (3β,5α,25R)−3-hydroxyspirostan-12-one. Neohecogenin is a C-27 steroidal sapogenin that shares the characteristic spirostan skeleton — a bicyclic system formed by rings E and F — and differs from hecogenin in the orientation or oxidation state at specific ring positions. Saponins are glycosides which, after acid hydrolysis, liberate sugar(s) and an aglycone (sapogenin) which can be triterpenoid or steroidal in nature. In the monosaccharide form discussed here, the single sugar unit is β-D-glucose in its pyranose ring form, attached at the C-3 position of the sapogenin backbone — the same position employed by many naturally occurring spirostanol saponins.

1.2 Relationship to Multi-Sugar Neohecogenin Glycosides

NeoHecogenin can be found in nature conjugated to one or multiple sugar units, generating a family of related glycosides of escalating structural complexity. Four new steroidal saponins, chloromalosides A–D, were isolated from the rhizomes of Chlorophytum malayense; their structures were elucidated to be neohecogenin saponins bearing complex oligosaccharide chains at the C-3 position, including combinations of glucopyranose, xylopyranose, and galactopyranose units. The simple monosaccharide form — neohecogenin 3-O-β-D-glucopyranoside — therefore represents the most structurally minimal natural glycoside of neohecogenin.

1.3 Natural Botanical Sources

Neohecogenin and its glycosides have been isolated from several plant species belonging to families in the order Asparagales, most prominently the genera Agave, Chlorophytum, and related taxa. Hecogenin, a closely related steroidal sapogenin, is found abundantly in the leaves of Agave genus species such as Agave sisalana, Agave cantala, Agave aurea, and many more. Hecogenin is a steroidal saponin found in plants of the Agave and Tribulus terrestris L. genus.

Neohecogenin specifically has been documented as a constituent of several Chlorophytum species. Chlorophytum species are known to contain steroidal saponins including neohecogenin, neotigogenin, stigmasterol, and tokorogenin. The major active steroidal saponins reported in Chlorophytum borivilianum include hecogenin, neohecogenin, neotigogenin, stigmasterol, and tokorogenin. Additionally, neohecogenin-bearing complex glycosides (chloromalosides A and C) were isolated from the rhizomes of Chlorophytum malayense.

In the dietary supplement industry, neohecogenin 3-O-β-D-glucopyranoside appears in product formulations alongside other saponin-derived compounds from Chlorophytum borivilianum (safed musli) and Tribulus terrestris extracts. Commercial supplement labels have listed NeoHecogenine-3-0-Beta-D-Glycopyranoside alongside Desoxydiosgenin as constituents derived from safed musli extract (Chlorophytum borivilianum root, standardized to 40% saponins) and Tribulus terrestris extract.

2. Traditional and Historical Use

2.1 Agave Species in Mesoamerican and African Traditional Medicine

The broader Agave genus — a primary botanical source of hecogenin and neohecogenin sapogenins — has an extremely long history of human use. In Central America, where the genus probably originated, Agave has been used by humans as a source of food, drink, and fibre for at least 9,000 years. Indigenous groups across Mesoamerica recognized the value of agave long before it became a staple of the spirits industry; the Aztecs and Mayans relied on it for sustenance, creating pulque from its sap, and the plant provided strong fibres for clothing, rope, and mats; agave also played a role in medicine, treating wounds and digestive ailments.

Agave sisalana, one of the richest sources of spirostanol sapogenins including neohecogenin, originates from Central America, probably southern Mexico, based on the strength of traditional local usage. Sisal is a folk remedy for dysentery, leprosy sores, and syphilis. Indigenous and folk medicinal uses of A. sisalana include treatment of wounds, skin conditions, and digestive complaints. The genus Agave contains more than 200 species, and many members of the genus find extensive application in African and Asian traditional medicine.

It is important to note that traditional medicinal uses were associated with whole plant preparations (leaf sap, root decoctions, or expressed juices), not with isolated glycosides. The identification of neohecogenin 3-O-β-D-glucopyranoside as a specific chemical entity is a product of modern phytochemical analysis; no traditional culture is documented as using this compound in isolated or standardized form.

2.2 Chlorophytum borivilianum (Safed Musli) in Ayurvedic and Related Traditions

The second principal botanical matrix containing neohecogenin — safed musli (Chlorophytum borivilianum) — has its own independent tradition of medicinal use on the Indian subcontinent. Chlorophytum borivilianum Santapau & Fernandes (Liliaceae), also known as "Safed Musli," is a traditional rare Indian medicinal herb which has many therapeutic applications in Ayurvedic, Unani, Homeopathic, and Allopathic systems of medicine. The appreciation of the medicinal value of safed musli tubers has been made in ancient Indian medicine literature from the 11th century AD.

In Ayurveda, safed musli is categorized as a "Vajikaran Rasayan" and used to treat various diseases such as leucorrhea, gonorrhea, impotence, infertility, diarrhea, and dysentery. It is considered a "Divya Aushad" or white gold and used as a health-promoting drug or tonic in the ayurvedic medicinal system. Its roots (tubers) are widely used for various therapeutic applications including physical illness and weakness, as an aphrodisiac agent and revitalizer, as a general sex tonic, remedy for diabetes, arthritis and increasing body immunity, curative for natal and postnatal problems, for rheumatism and joint pains, increased lactation in feeding mothers, as an antimicrobial, anti-inflammatory, and antitumor agent, and in diarrhea, dysentery, gonorrhea, and leucorrhea.

The tubers of C. borivilianum contain saponins and have aphrodisiac, adaptogenic, antiaging, health restorative, and health promoting properties; the root contains steroidal and triterpenoidal saponins, sapogenins, and fructans which act as therapeutic agents and play a vital role in many therapeutic applications. Fasciculated roots of Chlorophytum borivilianum are used as a tonic and constitute an important ingredient of over 20 Ayurvedic and Unani preparations.

The traditional use of safed musli preparations involves dried or powdered root material and multi-component formulations; again, the specific glycoside neohecogenin 3-O-β-D-glucopyranoside was not isolated or identified as an individual compound within these traditions. The saponin content as a whole was responsible for attributed traditional activity.

3. Key Constituents, Chemical Context, and Mechanisms of Action

3.1 Structural Chemistry and Classification

NeoHecogenin 3-O-β-D-glucopyranoside belongs to the spirostanol (or spirostane) class of steroidal saponins. The spirostane scaffold consists of a cholesterol-derived steroidal tetracyclic A-B-C-D ring system augmented by two additional rings (E and F), the latter forming the characteristic spiro-bicyclic configuration that defines this subclass. Saponins are glycosides which, after acid hydrolysis, liberate sugar(s) and an aglycone (sapogenin) which can be triterpenoid or steroidal in nature; steroidal saponins and sapogenins have attracted significant attention as important natural anti-inflammatory compounds capable of acting on the activity of several inflammatory cytokines in various inflammatory models.

The parent aglycone hecogenin is a steroidal sapogenin with a spectrum of pharmacological activities and is perhaps the most studied sapogenin of Agave; it is an important precursor of steroid hormones. This phytosteroid (hecogenin) is used as initial material for the synthesis of steroidal drugs in the pharmaceutical industry. Neohecogenin is the C-25 or ring-E isomer of hecogenin, and the published spectroscopic data for the monosaccharide glucopyranoside derivative have been catalogued in specialist phytochemical reference works.

Chlorophytum borivilianum is a rich source of over 25 alkaloids, vitamins, proteins, carbohydrates, steroids, saponins, potassium, calcium, magnesium, phenol, resins, mucilage, and polysaccharides, and also contains high quantities of simple sugars including sucrose, glucose, fructose, galactose, mannose, and xylose. Among these, the steroidal saponins — including neohecogenin glycosides — are considered principal bioactive constituents.

3.2 Mechanisms Established for Related Steroidal Saponins

Because no mechanism-of-action studies have been published that isolate neohecogenin 3-O-β-D-glucopyranoside as a sole test compound, the available mechanistic data pertain to its closely related aglycone (hecogenin) and to hecogenin acetate, as reviewed in peer-reviewed pharmacological literature. These data are presented here because they represent the closest evidence base but should not be directly extrapolated to the glycoside without confirmatory studies.

A 2023 pharmacological review compiled articles showing the pharmacological activity and mechanism of action of hecogenin, its acetate, and its derivatives; this compilation showed that the compounds can act in different pathologies affecting many systems of the human body; they showed pharmacological properties in inflammation, mediating cytokines, cells, and environment, and also participated in tumoral processes by pathways including PPARγ, ERK½, and MMP-2, and showed antimicrobial effects against organisms like Candida and Aedes aegypti larvae.

With regard to inflammation and pain, hecogenin has been shown in preclinical studies to possess anti-inflammatory properties that inhibit hyperalgesia development when induced with carrageenan, reducing dopamine and TNF-alpha production; the compound was concluded to block the neural transmission of pain in the spinal cord region by inhibiting a cytokine mechanism. Hecogenin acetate exhibited considerable antihyperalgesic activity in the case of hyperalgesia induced in mice by carrageenan, TNF-α, dopamine, and PGE2, and it reduced levels of pro-inflammatory cytokines such as IL-1β and inhibited Fos-like expression in the spinal cord.

Another study reported the antinociceptive activity of hecogenin acetate and evaluated the involvement of periaqueductal gray in the antinociception mechanism; systemic administration to male Swiss Webster mice increased Fos expression in the periaqueductal gray and thereby produced antinociception mediated by opioid receptors and by activation of descending pain-inhibitory pathways.

Regarding possible diuretic activity, saponins are known for their various biological activities affecting the nervous, cardiovascular, and gastrointestinal systems, as well as their involvement in inflammatory and infectious conditions. Studies on hecogenin specifically have examined renal effects, noting aldosterone synthase inhibition as a potential mechanism of diuretic action.

4. Scientific Evidence by Area of Use

Important methodological caveat: No published peer-reviewed clinical trials or human studies have been retrieved that tested neohecogenin 3-O-β-D-glucopyranoside as an isolated compound. The scientific evidence below therefore derives from: (a) studies on the parent aglycone hecogenin or neohecogenin in preclinical models, (b) studies on the plant extracts (Agave spp. or Chlorophytum borivilianum) that contain neohecogenin as one of multiple constituents, and (c) studies on closely related spirostanol saponins. All evidence discussed here is preliminary to weak with respect to the specific monosaccharide glucopyranoside in question.

4.1 Anti-Inflammatory Activity

Hecogenin is a sapogenin found in Agave sisalana species that has been used extensively in research evaluating anti-inflammatory, antifungal, hypotensive, anti-nociceptive activity, and cancer applications. Anti-inflammatory studies have included topical application of hecogenin and its combination with fluticasone on skin lesions in a dermatitis model involving Balb/c mice in which dermatitis was induced by repeated application of 2,4-dinitrofluorobenzene.

An anti-inflammatory activity through cellular and non-cellular components such as neutrophils and cytokines was documented in preclinical investigations; researchers also proposed that hecogenin and its acetate could potentially serve as alternatives to opioids due to their antagonistic action without motor damage. Hecogenin exhibits anti-inflammatory effects, reducing TNF-α and IL-6 levels in various preclinical models.

Evidence strength: Preclinical (animal and cell-based) only. No controlled human trials are available for the isolated glycoside compound.

4.2 Antinociceptive and Anti-Hyperalgesic Activity

Both hecogenin and hecogenin acetate possess documented potential pharmacological implications, including anti-hyperalgesic and antinociceptive effects, with cardioprotective effects also reported in preclinical literature. Activities on descending pain pathways, edema, gastroprotection, and pulmonary inflammation such as asthma have been reported in preclinical research on hecogenin-type compounds.

Evidence strength: All evidence is animal-model-based (rodent). No human/clinical data exist for the specific glycoside.

4.3 Antitumor and Cytotoxic Activity

Neohecogenin glycosides — particularly the complex multi-sugar derivatives — have been investigated in vitro for cytotoxicity. A cytotoxic steroidal glycoside was isolated from Chlorophytum malayense Ridley and its structure was characterized as neohecogenin 3-O-β-D-glucopyranosyl(1→2)-[β-D-xylopyranosyl(1→3)]-β-D-glucopyranosyl(1→4)-β-D-galactopyranoside (chloromaloside A). In seven cell lines originating from solid tumors, C. malayense saponin chloromaloside A has been shown to exert a cytotoxic effect that was weaker than that of microtubule destabilizing agent colchicine and topoisomerase II inhibitor ellipticine.

A wide range of herbs from the genus Chlorophytum (Asparagaceae) are known for their therapeutic potential with a vast range of pharmacologically important saponins; the important plants of the genus like C. borivilianum, C. malayense, C. comosum, and C. arundinaceum have steroidal saponins which have attracted attention due to their structural diversity and therapeutic capability; the saponins from C. malayense and C. comosum have demonstrated anti-tumor properties and cytotoxicity against cancerous cell lines.

For the simpler monosaccharide form (neohecogenin 3-O-β-D-glucopyranoside specifically), in vitro cytotoxicity data have not been identified in peer-reviewed literature from the searches conducted for this article. Regarding hecogenin aglycone: studies published in International Journal of Oncology examined the different contributions of apoptosis to the anti-proliferative effects of diosgenin and other plant steroids, including hecogenin and tigogenin, on human 1547 osteosarcoma cells.

Evidence strength: Preclinical in vitro only for multi-sugar neohecogenin glycosides; animal and in vitro for related hecogenin aglycone. No human trials.

4.4 Aphrodisiac, Androgenic, and Reproductive Effects

This area of claimed activity is predominantly associated with whole-extract preparations of Chlorophytum borivilianum rather than with any individual neohecogenin glycoside. Some reported therapeutic and pharmacological properties of safed musli include aphrodisiac, immunomodulatory, antimutagenic, antidiabetic, antioxidant, antiulcer, adaptogenic, and antimicrobial effects. It has spermatogenic properties and is found useful in curing impotency, and is now considered an alternative "Viagra."

These claims arise from traditional use and from limited preclinical and preliminary human studies on whole safed musli root preparations — which are mixtures of dozens of phytochemicals — not from isolated neohecogenin 3-O-β-D-glucopyranoside.

Evidence strength: The evidence specifically attributable to neohecogenin 3-O-β-D-glucopyranoside as an isolated compound is absent. Weak-to-modest evidence exists for whole C. borivilianum extract in preclinical models.

4.5 Gastroprotective and Antiulcer Activity

Hecogenin has exhibited a potential role in the management of a number of disorders including inflammation, arthritis, cancer, gastric ulcer, cardiotonic activity, and larvicidal activity. Gastroprotective effects have been documented for hecogenin in rodent ulcer models, and the hecogenin pharmacology review literature lists antiulcerogenic activity as one of the compound class's documented activities. These findings have not been extended to clinical studies or to the specific glucopyranoside derivative.

Evidence strength: Preclinical only; no data specific to neohecogenin 3-O-β-D-glucopyranoside.

4.6 Diuretic and Cardiovascular Effects

Saponins are known for their various biological activities affecting the nervous, cardiovascular, and gastrointestinal systems, as well as their involvement in inflammatory and infectious conditions. Diuretic effects via aldosterone synthase inhibition have been studied for hecogenin in preclinical models, and cardioprotective effects have been reported in preclinical literature on hecogenin-class compounds. These findings are not directly applicable to the monosaccharide glucopyranoside without independent evidence.

Evidence strength: Preclinical; class-based extrapolation only.

5. Body Systems and Health Areas of Association

Based on the available evidence for hecogenin/neohecogenin sapogenins and for whole-extract preparations of their source plants, the following body systems and health areas have been the subjects of research (all at a preclinical level unless otherwise stated):

• Musculoskeletal / Inflammatory system: Hecogenin shows potential as a safer alternative for treating rheumatoid arthritis. Anti-arthritic activity via suppression of pro-inflammatory cytokines has been documented in preclinical rodent models.
• Nervous system / Pain pathways: Antinociceptive and anti-hyperalgesic activities involving descending spinal pain pathways and opioid receptor modulation have been reported in preclinical studies for hecogenin acetate.
• Gastrointestinal system: Gastroprotective and antiulcerogenic effects have been reported in rodent models for hecogenin.
• Reproductive system: In Ayurvedic tradition, safed musli (a principal source of neohecogenin glycosides) is used to treat impotence, infertility, leucorrhea, and gonorrhea.
• Immune system: Immunomodulatory properties are among the reported pharmacological activities of safed musli extracts.
• Cardiovascular / Renal system: Diuretic effects via aldosterone synthase inhibition and cardioprotective effects have been described at the preclinical level for hecogenin-class compounds.
• Oncology (in vitro only): Cytotoxic effects against solid tumor cell lines have been shown for neohecogenin-bearing complex glycosides from Chlorophytum malayense in cell culture.

6. Dosage Forms and Reported Dosages

No peer-reviewed human clinical trial has been identified that establishes a specific dose for isolated neohecogenin 3-O-β-D-glucopyranoside. The compound appears in dietary supplements as part of saponin-standardized extract blends. One commercial product formulation listed NeoHecogenine-3-0-Beta-D-Glycopyranoside as part of a proprietary blend of 700 mg per capsule (serving size: 1 capsule, 60 capsules per container), alongside other saponin compounds from safed musli extract (standardized to 40% saponins) and Tribulus terrestris extract. The proportion of the specific glycoside within such blends is undisclosed in such commercial labeling, and no dose-ranging or pharmacokinetic study for the isolated compound has been identified.

For whole safed musli root powder — the traditional preparation containing neohecogenin among many other compounds — doses of approximately 3–6 grams per day of the dried root powder are referenced in traditional Ayurvedic practice contexts, though formally validated clinical dose-finding studies for this preparation specifically are limited.

Major biochemical constituents of safed musli are carbohydrates (approximately 42%), protein (80–90% on a dry basis), fibres (3–4%), saponins (2–17%), and alkaloids (15–25%). The saponin fraction itself — within which neohecogenin glycosides contribute — thus represents a minority of total root mass and varies substantially between samples.

7. Safety Considerations and Interactions

7.1 Class-Level Hemolytic Potential

Saponins as a structural class carry a well-characterized potential for hemolytic activity. Saponins can be toxic if given intravenously; these compounds are known for their hemolytic activity on human erythrocytes, which depends on the type of aglycone and sugar chains; this property is due to the interaction with sterols present in the erythrocyte membrane, which leads to an increase in membrane permeability and consequent loss of hemoglobin.

Many saponins possess harmful hemolytic toxicity, which can cause the lysis of erythrocytes and thereby hamper their applications in medicine; saponins bear a hydrophobic steroid/triterpenoid moiety and hydrophilic carbohydrate branches, and the majority demonstrate a broad range of prominent pharmacological activities, yet many also possess hemolytic toxicity.

Saponins are well known for both cytotoxicity and hemolysis; however, the hemolytic activity of saponins inducing toxicity in most animals is a major drawback for their clinical development, though these two properties are not necessarily linked since they can proceed by different mechanisms; the exact mechanism of the rupture of erythrocyte membranes by saponins is not yet clearly understood, but it has been found to be correlated with amphiphilic properties. The degree to which neohecogenin 3-O-β-D-glucopyranoside specifically exhibits hemolytic activity at relevant oral doses has not been characterized in published literature.

7.2 Oral vs. Parenteral Route Considerations

Steroidal saponins are possibly decomposed into their corresponding constituent aglycones and sugar moieties via acidolysis under the acid environment of the stomach; the secondary substances are further metabolized into other small molecules through methylation, hydroxylation, and similar processes under the assistance of enzymes and bacteria inhabiting the digestive system; these metabolites themselves were found to be non-toxic in some models, indicating a lack of toxicity for oral administration. This metabolic conversion on oral ingestion is considered to meaningfully reduce the systemic hemolytic risk compared to intravenous administration.

7.3 Potential for Gastrointestinal Effects

Some saponin-containing plants are toxic to ruminants, leading to gastroenteritis, diarrhea, and even liver and kidney degeneration. In humans, saponin-rich preparations can cause gastrointestinal irritation, nausea, and loose stools at higher doses. These effects have not been formally characterized for neohecogenin 3-O-β-D-glucopyranoside in isolation.

7.4 Steroid Precursor Concerns

Hecogenin is a steroidal sapogenin obtained from the genus Agave, used in the pharmaceutical industry to produce oral contraceptives and other steroid hormones. Because hecogenin and related spirostanol sapogenins serve as precursors in the industrial synthesis of steroid hormones, there is a theoretical concern about endocrine system interactions, particularly when used in high-concentration standardized extracts. No human pharmacokinetic or endocrine safety study for neohecogenin 3-O-β-D-glucopyranoside has been identified in the published literature. This theoretical concern cannot be quantified from currently available data.

7.5 Absence of Established Safety Profile

There are no published toxicology studies, pharmacokinetic studies, or safety trials for neohecogenin 3-O-β-D-glucopyranoside as an isolated compound at the time of this writing. No established acceptable daily intake, no-observed-adverse-effect level (NOAEL), tolerable upper intake level, or maximum tolerated dose has been determined in peer-reviewed literature for this specific compound. The compound does not appear in any pharmacopeia monograph, WHO herbal medicine monograph, or European Medicines Agency/EFSA scientific opinion as an isolated entity.

8. Summary and State of the Evidence

NeoHecogenin 3-O-β-D-glucopyranoside is a spirostanol steroidal saponin in which the sapogenin neohecogenin is glycosylated at the C-3 position with a single β-D-glucopyranose unit. It is a natural phytochemical constituent of species in the genera Agave and Chlorophytum, plants with long traditions of folk and Ayurvedic use. Its parent aglycone class (hecogenin and related sapogenins) has been studied extensively at a preclinical level and shown activities spanning anti-inflammatory, antinociceptive, gastroprotective, antitumor (in vitro), and diuretic areas. Complex glycoside derivatives of neohecogenin from Chlorophytum malayense have demonstrated in vitro cytotoxicity against tumor cell lines.

However, no peer-reviewed human clinical trials, no established pharmacokinetics, and no validated safety data exist for neohecogenin 3-O-β-D-glucopyranoside as an isolated compound. Its presence in commercial dietary supplements is documented, but dosing rationale is not grounded in clinical evidence. The entire current evidence base relies on preclinical (animal and cell culture) studies of structurally related compounds and on clinical/traditional evidence for multi-constituent plant extract preparations. All purported health effects of the isolated glycoside remain unsubstantiated at the clinical level.

References

• Ahmad, V.U. & Basha, A. (eds.) — "Neohecogenin 3-O-β-D-Glucopyranoside," in Spectroscopic Data of Steroid Glycosides: Stigmastanes, Furostanes, Spirtostanes, Springer (2006)
• Borges MADH et al. — "Hecogenin and its derivates: A pharmacology review." Biomedicine & Pharmacotherapy 159:114251 (2023). PMID 36641922
• Ingawale DK & Patel SS — "Anti-inflammatory potential of hecogenin on atopic dermatitis and airway hyper-responsiveness by regulation of pro-inflammatory cytokines." PubMed PMID 31039648
• Borges MADH et al. — "Hecogenin and its derivates: A pharmacology review." Biomed Pharmacother, ScienceDirect (2023)
• ScienceDirect Topics — "Hecogenin — an overview" (compiled from Biomedicine & Pharmacotherapy, 2023)
• Saponins of Agave: Chemistry and bioactivity. Phytochemistry (2016)
• Mimaki Y et al. — "Steroidal saponins from Chlorophytum malayense" — Phytochemistry (1990)
• Qui et al. — "Cytotoxic steroidal glycoside isolated from Chlorophytum malayense Ridley (chloromaloside A)." Planta Medica (2000). DOI 10.1055/s-2000-8600
• Singh D et al. — "Chlorophytum borivilianum: a white gold for biopharmaceuticals and neutraceuticals." PubMed PMID 19751181
• MedCrave — "Safed musli Chlorophytum borivilianum" (2018)
• Journal of Ayurveda and Integrated Medical Sciences — "Chlorophytum borivilianum (Safed Musli): Nature's Wonder Gift" (2021)
• International Journal of Pharmacy and Pharmaceutical Sciences — "Saponins and Sapogenins of Agave with Respect to Diverse Pharmacological Role of Hecogenin" (2020)
• ResearchGate — "Saponins and Sapogenins of Agave with Respect to Diverse Pharmacological Role of Hecogenin" (2020)
• ResearchGate — "Cytotoxic Spirostane-Type Saponins from the Roots of Chlorophytum borivilianum"
• PMC — "Diuretic effects of Hecogenin and Hecogenin acetate via aldosterone synthase inhibition" (PMC11170188)
• PMC — "Effects of Saponins on Lipid Metabolism: A Review of Potential Health Benefits in the Treatment of Obesity" (PMC6273086)
• Hu et al. — "Prediction of Hemolytic Toxicity for Saponins by Machine-Learning Methods." Chemical Research in Toxicology, ACS (2019)
• Correlation among cytotoxicity, hemolytic activity and the composition of steroidal saponins from Paris L. Journal of Ethnopharmacology (2013)
• PMC — "Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis: Sub-acute and chronic toxicity studies on dogs" (PMC5698098)
• PlantUse / PROTA — "Agave sisalana" (Agave sisalana PROTA entry)
• ResearchGate — "Agave sisalana: A Plant with High Chemical Diversity and Medicinal Importance" (2014)
• ProQuest — "Saponin: A Wonder Drug from Chlorophytum Species"